Literature DB >> 10931993

Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI?

R G Beets-Tan1, G L Beets, A C Borstlap, T K Oei, T M Teune, M F von Meyenfeldt, J M van Engelshoven.   

Abstract

BACKGROUND: We compared high-resolution magnetic resonance imaging (MRI) with computed tomography (CT) in the assessment of tumor infiltration in surrounding structures for locally advanced primary and recurrent rectal cancer.
METHODS: Twenty-six patients with operable, locally advanced rectal cancer (15 recurrent and 11 primary) were evaluated with conventional pelvic CT and 1.5-T high-resolution MRI with a quadrature phased-array coil. The images were scored for invasion of nine neighboring pelvic structures, and the results were compared with surgical and histologic findings.
RESULTS: A total of 234 structures in 26 patients was evaluated for tumor invasion. For MRI the, sensitivity was 97% and the specificity 98%; for CT, the sensitivity was 70% and the specificity was 85%. The difference in performance was statistically significant (p<0.001). The failure most frequently made on CT was the false-positive prediction of pelvic floor and piriform muscle invasion (14), whereas MRI showed only four false-positive predictions. MRI correctly predicted all four cases of sacral bone invasion, three of which were missed by CT. MRI was accurate in 20 patients (80%) and CT in only five patients (19%).
CONCLUSION: High-resolution MRI using a quadrature phased-array coil is highly accurate and superior to CT in predicting tumor infiltration in surrounding structures for locally advanced primary or recurrent rectal cancer and is recommended in the preoperative work-up of these tumors.

Entities:  

Mesh:

Year:  2000        PMID: 10931993     DOI: 10.1007/s002610000086

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  23 in total

Review 1.  Evolution of imaging in rectal cancer: multimodality imaging with MDCT, MRI, and PET.

Authors:  Siva P Raman; Yifei Chen; Elliot K Fishman
Journal:  J Gastrointest Oncol       Date:  2015-04

2.  The role of FDG-PET/CT in the detection of recurrent colorectal cancer.

Authors:  Jana Votrubova; Otakar Belohlavek; Monika Jaruskova; Martin Oliverius; Radka Lohynska; Kristina Trskova; Eva Sedlackova; Ludmila Lipska; Vladimira Stahalova
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-25       Impact factor: 9.236

Review 3.  Adjuvant therapies for colorectal cancer.

Authors:  Suzanne Kosmider; Lara Lipton
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

Review 4.  [Progress in diagnostics of anorectal disorders. Part II: radiology].

Authors:  F G Bader; R Bouchard; A Lubienski; R Keller; L Mirow; R Czymek; J K Habermann; H-P Bruch; U J Roblick
Journal:  Chirurg       Date:  2008-05       Impact factor: 0.955

5.  Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations.

Authors:  D M Koh; G Brown; L Temple; H Blake; A Raja; P Toomey; N Bett; S Farhat; A R Norman; I Daniels; J E Husband
Journal:  Eur Radiol       Date:  2005-05-03       Impact factor: 5.315

6.  MRI can be used to assess advanced T-stage colon carcinoma as well as rectal carcinoma.

Authors:  Akitoshi Inoue; Shinichi Ohta; Norihisa Nitta; Masahiro Yoshimura; Tomoharu Shimizu; Masaji Tani; Ryoji Kushima; Kiyoshi Murata
Journal:  Jpn J Radiol       Date:  2016-10-18       Impact factor: 2.374

7.  Management of locally advanced primary and recurrent rectal cancer.

Authors:  Johannes H W de Wilt; Maarten Vermaas; Floris T J Ferenschild; Cornelis Verhoef
Journal:  Clin Colon Rectal Surg       Date:  2007-08

8.  Assessment of the prognostic factors for a local recurrence of rectal cancer: the utility of preoperative MR imaging.

Authors:  Young Taik Oh; Myeong Jin Kim; Joon Seok Lim; Joo Hee Kim; Kang Young Lee; Nam Kyu Kim; Won Ho Kim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2005 Jan-Mar       Impact factor: 3.500

9.  Association between surgeon characteristics and their preferences for guideline-concordant staging and treatment for rectal cancer.

Authors:  Mary E Charlton; Lorren R Mattingly-Wells; Jorge E Marcet; Brenna C McMahon Waldschmidt; John W Cromwell
Journal:  Am J Surg       Date:  2014-06-08       Impact factor: 2.565

10.  Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology.

Authors:  Holger Amthauer; Timm Denecke; Beate Rau; Bert Hildebrandt; Michael Hünerbein; Juri Ruf; Ulrike Schneider; Matthias Gutberlet; Peter M Schlag; Roland Felix; Peter Wust
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.